Q3 2024 Holdings
Filed 2024-11-14 | 82 holdings | $8.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scilex Holding Co(SCLXUSD) | SH | 80880W106 | $241.5K | 261,179 | 0.0% |
| Regulus Therapeutics Inc(RGLS) | SH | 75915K309 | $1.2M | 766,834 | 0.0% |
| An2 Therapeutics Inc(ANTX) | SH | 037326105 | $2.1M | 1,999,997 | 0.0% |
| Newamsterdam Pharma Co NV | SH | N62509117 | $2.3M | 333,333 | 0.0% |
| Metagenomi Inc(MGX) | SH | 59102M104 | $2.8M | 1,305,239 | 0.0% |
| Surrozen Inc(SRZN) | SH | 86889P208 | $3.4M | 282,580 | 0.0% |
| Adagio Medical Holdings Inc(ADGM) | SH | 00534B100 | $3.4M | 1,333,926 | 0.0% |
| Protara Therapeutic Inc(TARA) | SH | 74365U107 | $3.5M | 1,900,000 | 0.0% |
| Lexeo Therapeutics Inc(LXEO) | SH | 52886X107 | $4.9M | 546,554 | 0.1% |
| Perceptive Capital Solutions | SH | G70077105 | $7.5M | 750,000 | 0.1% |
| Cidara Thereapeutics Inc(CDTX) | SH | 171757206 | $7.6M | 703,080 | 0.1% |
| Boundless BIO Inc(BOLD) | SH | 10170A100 | $7.6M | 2,180,631 | 0.1% |
| Chimerix Inc(CMRXEUR) | SH | 16934W106 | $8.2M | 8,800,000 | 0.1% |
| Avalo Therapeutics Inc(AVTX) | SH | 05338F306 | $9.2M | 967,000 | 0.1% |
| Arvinas Inc(ARVN) | SH | 04335A105 | $10.4M | 421,348 | 0.1% |
| Adicet BIO Inc(TORCEUR) | SH | 007002108 | $10.9M | 7,541,000 | 0.1% |
| Xencor Inc(XNCR) | SH | 98401F105 | $11.6M | 575,000 | 0.1% |
| Cervomed Inc(CRVO) | SH | 15713L109 | $11.9M | 817,120 | 0.1% |
| Werewolf Therapeutics Inc(HOWL) | SH | 95075A107 | $13.0M | 6,144,881 | 0.2% |
| Zura BIO LTD(ZURA) | SH | G9TY5A101 | $13.1M | 3,217,503 | 0.2% |
| Tenaya Therapeutics Inc(TNYA) | SH | 87990A106 | $13.5M | 6,982,587 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | SH | 729139105 | $14.4M | 1,281,000 | 0.2% |
| Insmed Inc(INSM) | SH | 457669307 | $14.6M | 200,000 | 0.2% |
| VOR Biopharma Inc | SH | 929033108 | $15.9M | 22,748,880 | 0.2% |
| Third Harmonic BIO Inc(THRD) | SH | 88427A107 | $17.4M | 1,280,826 | 0.2% |
| Nuvalent Inc(NUVL) | SH | 670703107 | $18.0M | 176,281 | 0.2% |
| Aerovate Therapeutics Inc | SH | 008064107 | $19.2M | 9,192,092 | 0.2% |
| Immatics NV(IMTX) | SH | N44445109 | $20.0M | 1,750,000 | 0.2% |
| Taysha Gene Therapies Inc(TSHA) | SH | 877619106 | $21.9M | 10,872,503 | 0.3% |
| Sera Prognostics Inc(SERA) | SH | 81749D107 | $23.7M | 3,032,808 | 0.3% |
| Alto Neuroscience Inc(ANRO) | SH | 02157Q109 | $23.7M | 2,075,154 | 0.3% |
| Enliven Therapeutics Inc(ELVN) | SH | 29337E102 | $27.1M | 1,061,233 | 0.3% |
| C4 Therapeutics Inc(CCCC) | SH | 12529R107 | $27.8M | 4,878,000 | 0.3% |
| Solid Biosciences Inc(SLDB) | SH | 83422E204 | $30.2M | 4,330,446 | 0.3% |
| Iteos Therapeutics Inc(5E7) | SH | 46565G104 | $32.5M | 3,184,711 | 0.4% |
| Fulcrum Therapeutics Inc(FULC) | SH | 359616109 | $36.5M | 10,229,099 | 0.4% |
| Acumen Pharmaceuticals Inc(ABOS) | SH | 00509G209 | $37.0M | 14,932,063 | 0.4% |
| MBX Biosciences Inc(MBX) | SH | 55287L101 | $39.3M | 1,511,334 | 0.5% |
| Larimar Therapeutics Inc(LRMR) | SH | 517125100 | $39.6M | 6,045,351 | 0.5% |
| Ideaya Biosciences Inc(IDYA) | SH | 45166A102 | $42.7M | 1,347,252 | 0.5% |
| Praxis Precision Medicines I(PRAX) | SH | 74006W207 | $43.8M | 761,955 | 0.5% |
| GH Research PLC(GHRS) | SH | G3855L106 | $44.7M | 6,686,689 | 0.5% |
| Bioage Labs Inc(BIOA) | SH | 09077V100 | $46.0M | 2,210,589 | 0.5% |
| Nkarta Inc(NKTX) | SH | 65487U108 | $48.8M | 10,805,129 | 0.6% |
| Bicycle Therapeutics PLC(BCYC) | SH | 088786108 | $51.0M | 2,253,000 | 0.6% |
| CG Oncology Inc(CGON) | SH | 156944100 | $52.7M | 1,397,433 | 0.6% |
| 4D Molecular Therapeutics in(FDMT) | SH | 35104E100 | $55.1M | 5,098,211 | 0.6% |
| Astria Therapeutics Inc(CATBUSD) | SH | 04635X102 | $56.2M | 5,105,213 | 0.6% |
| Acrivon Therapeutics Inc(ACRV) | SH | 004890109 | $58.4M | 8,340,508 | 0.7% |
| Mineralys Therapeutics Inc(MLYS) | SH | 603170101 | $58.7M | 4,850,984 | 0.7% |